Your Article Summary
Forest Laboratories, Inc. and Nycomed Announce a Conference Call to Review Publication of Daxas Phase III Clinical Trial Results
Forest Laboratories, 08/28/09
Forest Laboratories, Inc. , an international manufacturer and marketer of pharmaceutical products and Nycomed, a privately owned pharmaceutical company, will host a conference call on Friday, August 2009.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09
AMA meeting: Nap time mandate for on-call residents rejected
American Medical News , 11/25/09
AMA meeting: Delegate vote refines AMA stance on system reform
American Medical News , 11/25/09
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09
Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09
Article Search
Sponsor


See Latest Articles


